{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:23:28Z","timestamp":1773239008774,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jacadv.2025.102020","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:03:38Z","timestamp":1753401818000},"page":"102020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construct and Predictive Validity of the Kansas City Cardiomyopathy Questionnaire in Adult Congenital Heart Disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Ryan D.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4985","authenticated-orcid":false,"given":"Ajith P.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Dolgner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri","family":"Fedson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Broda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2025.102020_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009675","article-title":"Incidence and outcomes of advanced heart failure in adults with congenital heart disease","volume":"15","author":"Egbe","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102020_bib2","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/ehf2.13378","article-title":"Heart failure related to adult congenital heart disease: prevalence, outcome and risk factors","volume":"8","author":"Arnaert","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102020_bib3","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2023.03.422","article-title":"Morbidity and mortality in adult fontan patients after heart or combined heart-liver transplantation","volume":"81","author":"Lewis","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCOUTCOMES.114.001406","article-title":"Call for a disease-specific patient-reported outcome tool in adult congenital heart disease","volume":"7","author":"Cedars","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2025.102020_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2022.03.018","article-title":"Heart failure in adults with congenital heart disease","volume":"357","author":"Brida","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCOUTCOMES.115.002154","article-title":"Adult congenital heart disease patients experience similar symptoms of disease activity","volume":"9","author":"Cedars","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2025.102020_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","article-title":"Comparable performance of the Kansas City cardiomyopathy questionnaire in patients with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Joseph","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102020_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.102020_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.102020_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","article-title":"Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study","volume":"32","author":"Ekman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.102020_bib13","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.107.747568","article-title":"Evolving applications for patient-centered health status measures","volume":"118","author":"Spertus","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102020_bib14","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas city cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art Review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2005.11.021","article-title":"Health status identifies heart failure outpatients at risk for hospitalization or death","volume":"47","author":"Heidenreich","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jamacardio.2017.3983","article-title":"Association of serial Kansas city cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib17","article-title":"Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure","volume":"7","author":"Aldweib","year":"2022","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.jacadv.2025.102020_bib18","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015730","article-title":"Development of a novel adult congenital heart disease-specific patient-reported outcome metric","volume":"9","author":"Cedars","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2025.102020_bib20","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.jacc.2023.03.385","article-title":"Patient-reported outcomes after tetralogy of fallot repair","volume":"81","author":"Kovacs","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2019.08.012","article-title":"Advanced heart failure in adults with congenital heart disease","volume":"8","author":"Menachem","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102020_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.105.592410","article-title":"Arrhythmias in adult patients with congenital heart disease","volume":"115","author":"Walsh","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102020_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4330\/wjc.v9.i6.496","article-title":"Atrial tachyarrhythmia in adult congenital heart disease","volume":"9","author":"Karbassi","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib24","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jacc.2022.09.038","article-title":"Management of heart failure with arrhythmia in adults with congenital heart disease: JACC state-of-the-art Review","volume":"80","author":"Moore","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13144175","article-title":"Patient reported outcome measures in adults with Fontan circulatory failure","volume":"13","author":"Agorrody","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacadv.2025.102020_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/chd.12820","article-title":"More than the heart: hepatic, renal, and cardiac dysfunction in adult Fontan patients","volume":"14","author":"Byrne","year":"2019","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.jacadv.2025.102020_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.104.529800","article-title":"Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication","volume":"112","author":"Diller","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102020_bib28","first-page":"457","article-title":"Heart failure in adult congenital heart disease","volume":"38","author":"Burchill","year":"2020","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacadv.2025.102020_bib29","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.jacc.2019.09.004","article-title":"Advanced heart failure therapies for adults with congenital heart disease: JACC state-of-the-art Review","volume":"74","author":"Givertz","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102020_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.amjcard.2018.11.037","article-title":"Comparison of the Kansas city cardiomyopathy Questionnaire and Minnesota living with heart failure Questionnaire in predicting heart failure outcomes","volume":"123","author":"Yee","year":"2019","journal-title":"Am J Cardiol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25004442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25004442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:22:58Z","timestamp":1773166978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25004442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2772963X25004442"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102020","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construct and Predictive Validity of the Kansas City Cardiomyopathy Questionnaire in Adult Congenital Heart Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102020"}}